CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis
Europe - BIT:1CVS - US1266501006 - Common Stock
68.37 EUR
+7.19 (+11.75%)
Overall 1CVS gets a fundamental rating of 3 out of 10. We evaluated 1CVS against 32 industry peers in the Health Care Providers & Services industry. 1CVS has a bad profitability rating. Also its financial health evaluation is rather negative. 1CVS is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year 1CVS was profitable.
In the past year 1CVS had a positive cash flow from operations.
1CVS had positive earnings in each of the past 5 years.
Each year in the past 5 years 1CVS had a positive operating cash flow.
1.2 Ratios
1CVS has a Return On Assets (1.75%) which is comparable to the rest of the industry.
1CVS has a Return On Equity of 5.86%. This is comparable to the rest of the industry: 1CVS outperforms 44.83% of its industry peers.
The Return On Invested Capital of 1CVS (4.57%) is comparable to the rest of the industry.
1CVS had an Average Return On Invested Capital over the past 3 years of 6.22%. This is in line with the industry average of 7.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | 5.86% | ||
| ROIC | 4.57% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1.3 Margins
The Profit Margin of 1CVS (1.17%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of 1CVS has declined.
The Operating Margin of 1CVS (2.65%) is worse than 65.52% of its industry peers.
In the last couple of years the Operating Margin of 1CVS has declined.
Looking at the Gross Margin, with a value of 13.82%, 1CVS is doing worse than 62.07% of the companies in the same industry.
1CVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.65% | ||
| PM (TTM) | 1.17% | ||
| GM | 13.82% |
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-18.43%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CVS is destroying value.
Compared to 1 year ago, 1CVS has less shares outstanding
1CVS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1CVS is higher compared to a year ago.
2.2 Solvency
1CVS has an Altman-Z score of 2.20. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
1CVS's Altman-Z score of 2.20 is fine compared to the rest of the industry. 1CVS outperforms 65.52% of its industry peers.
The Debt to FCF ratio of 1CVS is 13.91, which is on the high side as it means it would take 1CVS, 13.91 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1CVS (13.91) is worse than 65.52% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that 1CVS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.78, 1CVS is in line with its industry, outperforming 55.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 13.91 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.58
WACC7.87%
2.3 Liquidity
1CVS has a Current Ratio of 0.80. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.80, 1CVS is not doing good in the industry: 65.52% of the companies in the same industry are doing better.
A Quick Ratio of 0.62 indicates that 1CVS may have some problems paying its short term obligations.
The Quick ratio of 1CVS (0.62) is worse than 65.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.8 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
1CVS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.13%.
1CVS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.20% yearly.
Looking at the last year, 1CVS shows a small growth in Revenue. The Revenue has grown by 6.44% in the last year.
1CVS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.74% yearly.
EPS 1Y (TTM)-15.13%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%-1.09%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%8.42%
3.2 Future
1CVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.99% yearly.
1CVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.84% yearly.
EPS Next Y18.59%
EPS Next 2Y15.41%
EPS Next 3Y14.23%
EPS Next 5Y10.99%
Revenue Next Year5.85%
Revenue Next 2Y5.12%
Revenue Next 3Y5.31%
Revenue Next 5Y4.84%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.59, which indicates a correct valuation of 1CVS.
Based on the Price/Earnings ratio, 1CVS is valued cheaper than 86.21% of the companies in the same industry.
1CVS is valuated cheaply when we compare the Price/Earnings ratio to 27.49, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 11.05, the valuation of 1CVS can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1CVS indicates a rather cheap valuation: 1CVS is cheaper than 82.76% of the companies listed in the same industry.
1CVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.59 | ||
| Fwd PE | 11.05 |
4.2 Price Multiples
1CVS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1CVS is more expensive than 65.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.17 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
1CVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1CVS's earnings are expected to grow with 14.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y15.41%
EPS Next 3Y14.23%
5. Dividend
5.1 Amount
1CVS has a Yearly Dividend Yield of 3.48%.
1CVS's Dividend Yield is rather good when compared to the industry average which is at 2.30. 1CVS pays more dividend than 89.66% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.43, 1CVS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.48% |
5.2 History
The dividend of 1CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1CVS pays out 74.62% of its income as dividend. This is not a sustainable payout ratio.
1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP74.62%
EPS Next 2Y15.41%
EPS Next 3Y14.23%
BIT:1CVS (10/14/2025, 7:00:00 PM)
68.37
+7.19 (+11.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.11%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap86.72B
Analysts79.39
Price Target69.94 (2.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.48% |
Yearly Dividend2.27
Dividend Growth(5Y)5.72%
DP74.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.87%
Min EPS beat(2)22.99%
Max EPS beat(2)30.76%
EPS beat(4)3
Avg EPS beat(4)13.15%
Min EPS beat(4)-28.4%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)5.23%
EPS beat(12)10
Avg EPS beat(12)4.69%
EPS beat(16)14
Avg EPS beat(16)4.93%
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.02%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.67%
Revenue beat(12)9
Avg Revenue beat(12)2.1%
Revenue beat(16)13
Avg Revenue beat(16)2.16%
PT rev (1m)0.67%
PT rev (3m)5.74%
EPS NQ rev (1m)-1.08%
EPS NQ rev (3m)-15.91%
EPS NY rev (1m)0.15%
EPS NY rev (3m)7.79%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.59 | ||
| Fwd PE | 11.05 | ||
| P/S | 0.26 | ||
| P/FCF | 21.17 | ||
| P/OCF | 13.37 | ||
| P/B | 1.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)5.43
EY7.94%
EPS(NY)6.18
Fwd EY9.05%
FCF(TTM)3.23
FCFY4.72%
OCF(TTM)5.11
OCFY7.48%
SpS261.17
BVpS52.27
TBVpS-27.05
PEG (NY)0.68
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | 5.86% | ||
| ROCE | 6.23% | ||
| ROIC | 4.57% | ||
| ROICexc | 5% | ||
| ROICexgc | 21.47% | ||
| OM | 2.65% | ||
| PM (TTM) | 1.17% | ||
| GM | 13.82% | ||
| FCFM | 1.24% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexcg growth 3Y-10.65%
ROICexcg growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-18.43%
F-Score5
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 13.91 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.72% | ||
| Interest Coverage | -3.41 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 105.5% | ||
| Current Ratio | 0.8 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 2.2 |
F-Score5
WACC7.87%
ROIC/WACC0.58
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.13%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%-1.09%
EPS Next Y18.59%
EPS Next 2Y15.41%
EPS Next 3Y14.23%
EPS Next 5Y10.99%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%8.42%
Revenue Next Year5.85%
Revenue Next 2Y5.12%
Revenue Next 3Y5.31%
Revenue Next 5Y4.84%
EBIT growth 1Y-20.52%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year40.75%
EBIT Next 3Y19.75%
EBIT Next 5Y18.23%
FCF growth 1Y-72.95%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-63.11%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%